Circassia Pharmaceuticals Plc Director/PDMR Shareholding (3073L)
July 17 2017 - 1:28PM
UK Regulatory
TIDMCIR
RNS Number : 3073L
Circassia Pharmaceuticals Plc
17 July 2017
Persons Discharging Managerial Responsibilities / persons
closely associated with them (PDMR) Notification
17 June 2017: Circassia Pharmaceuticals plc (LSE: CIR).
1 - Details of the person discharging managerial
responsibilities/person closely associated
Name Steven Harris
----- --------------
2 - Reason for the notification
Position/status Chief Executive Officer
(PDMR)
-------------------------------- ------------------------
Initial notification/amendment* Initial Notification
-------------------------------- ------------------------
In case of amendment, N/A
please enter the previous
notification reference
number and explain the
error that this notification
needs amending
-------------------------------- ------------------------
3 - Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction monitor
Full name of entity* Circassia Pharmaceuticals
plc
------------------------ --------------------------
Legal Entity Identifier 2138006YAT138TOGA556
code
------------------------ --------------------------
In accordance with ISO
1744 LEI code
------------------------ --------------------------
4 - Details of the transaction(s)
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; (iv) each place where transactions have been conducted
Date Description of Aggregated Aggregated Total
Financial Transaction Price Volume Aggregated
Price
---------- ----------------------- ----------- ----------- ------------
17-Jun-17 Exercise of options GBP0.0008 535,375 GBP428.30
under the 2007
EMI scheme without
sale of shares
(options issued
under 2007 EMI
scheme expire
10 years following
grant)
---------- ----------------------- ----------- ----------- ------------
i. Exercise of options
Description of the financial Circassia Holdings Ltd
instrument, type of instrument 2007 Unapproved Option
Scheme
-------------------------------- -----------------------------------
Identification Code GB00BJVD3B28
-------------------------------- -----------------------------------
Nature of the transaction Exercise of options
-------------------------------- -----------------------------------
Currency GBP
-------------------------------- -----------------------------------
Price(s) and Volume (s) Price Volume Total
----------- -------- ----------
GBP0.0008p 535,375 GBP428.30
----------- -------- ----------
-------------------------------- -----------------------------------
Aggregated Information Price Volume Total
----------- -------- ----------
GBP0.0008p 535,375 GBP428.30
----------- -------- ----------
-------------------------------- -----------------------------------
Date of Transaction 17 June 2017
-------------------------------- -----------------------------------
Place of Transaction London: XLON
-------------------------------- -----------------------------------
For further information, please contact:
Circassia Pharmaceuticals plc
Julien Cotta, Company Secretary +44 (0) 1865 405560
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBRGDRCBBBGRR
(END) Dow Jones Newswires
July 17, 2017 13:28 ET (17:28 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2023 to Apr 2024
